Search Results  for '300254.SZ'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Shanxi C&Y Pharmaceutical Group Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jul 2015 Reuters Investment Profile 12 $20.00

Shanxi C&Y Pharmaceutical Group Co Ltd: Downgraded to Average

31 Jul 2015 Sadif Analytics Prime 3 $10.00

Thomson Reuters Stock Report - Shanxi C&Y Pharmaceutical Group Co Ltd (300254-SZ)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

30 Jul 2015 Thomson Reuters Stock Report 9 $25.00

Wright Investors Service Comprehensive Report for Shanxi C&Y Pharmaceutical Group Co Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

13 Jul 2015 Wright Reports 55 $75.00

Shanxi C&Y Pharmaceutical Group Co Ltd: Upgraded to Above Average

18 May 2015 Sadif Analytics Prime 3 $10.00

Company Snapshot - Shanxi Cy Pharmaceutical Co Ltd

A director at Shanxi Cy Pharmaceutical Co Ltd sold 1,920,000 shares at 25.416CNY and the significance rating of the trade was...

27 Oct 2014 Directors Deals Ltd. 1 $12.00